UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.564

Sortiert nach

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv1-iv21

2017

Volltextzugriff (PDF)

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v1-v27

2016

Volltextzugriff (PDF)

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

Radiotherapy and oncology, 2017-12, Vol.125 (3), p.439-444

2017

Volltextzugriff (PDF)

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi89-vi98

2013

Volltextzugriff (PDF)

Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2008-03, Vol.70 (3), p.685-692

2008

Volltextzugriff (PDF)

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Annals of oncology, 2020-12, Vol.31 (12), p.1597-1598

2020

Volltextzugriff (PDF)

Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands

Annals of oncology, 2012-10, Vol.23 (10), p.2743-2747

2012

Volltextzugriff (PDF)

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Annals of oncology, 2020-06, Vol.31 (6), p.798-806

2020

Volltextzugriff (PDF)

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Annals of oncology, 2014-08, Vol.25 (8), p.1462-1474

2014

Volltextzugriff (PDF)

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107532-107532, Article 107532

2024

Volltextzugriff (PDF)

SP-0008 STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS STANDARD IN EARLY-STAGE NSCLC

Radiotherapy and oncology, 2012-05, Vol.103, p.S3-S3

Senan, S

2012

Volltextzugriff (PDF)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Annals of oncology, 2020-02, Vol.31 (2), p.191-201

2020

Volltextzugriff (PDF)

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy

Radiotherapy and oncology, 2023-10, Vol.187, p.109823-109823, Article 109823

2023

Volltextzugriff (PDF)

256 INVITED Intensity Modulated Radiotherapy: Fixed-Beam and Arc Delivery Techniques for Locally Advanced Disease

European journal of cancer (1990), 2011, Vol.47, p.S60-S60

Senan, S

2011

Volltextzugriff (PDF)

ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Annals of oncology, 2019-04, Vol.30, p.ii25-ii25

2019

Volltextzugriff (PDF)

Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors

International journal of radiation oncology, biology, physics, 2018-03, Vol.100 (3), p.738-747

2018

Volltextzugriff (PDF)

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Annals of oncology, 2011-05, Vol.22 (5), p.1154-1163

2011

Volltextzugriff (PDF)

Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

Annals of oncology, 2019-04, Vol.30, p.ii27-ii28

2019

Volltextzugriff (PDF)

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107294-107294, Article 107294

2023

Volltextzugriff (PDF)

Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-01, Vol.30 (1), p.17-22

2018

Volltextzugriff (PDF)

Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy

Annals of oncology, 2015-10, Vol.26 (10), p.2196-2196

2015

Volltextzugriff (PDF)

The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma

Radiotherapy and oncology, 2021-03, Vol.156, p.223-230

2021

Volltextzugriff (PDF)

Curative Radiotherapy for Non-small Cell Lung Cancer: Practice Changing and Changing Practice?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-10, Vol.31 (10), p.678-680

2019

Volltextzugriff (PDF)

Deep Learning and Internet of Things (IoT) Based Monitoring System for Miners

Journal of mining science, 2022-04, Vol.58 (2), p.325-337

2022

Volltextzugriff (PDF)

SP-0761: Combining immunotherapy and thoracic radiotherapy in SCLC

Radiotherapy and oncology, 2020-11, Vol.152, p.S419-S419

Senan, S.

2020

Volltextzugriff (PDF)

1 – 25 von 1.564

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.295)
Mit Volltextzugriff
(1.438)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(788)
Life Sciences & Biomedicine
(547)
Humans
(339)
Oncology
(261)
Technology
(170)
Hematology, Oncology And Palliative Medicine
(169)
Radiology, Nuclear Medicine & Medical Imaging
(149)
Physical Sciences
(145)
Radiology
(110)
Lung Neoplasms - Radiotherapy
(94)
Engineering
(88)
Lung Neoplasms - Pathology
(84)
Biological And Medical Sciences
(82)
Radiotherapy
(78)
Computer Science
(75)
Female
(73)
Lung Cancer
(70)
Algorithms
(68)
Male
(67)
Respiratory System
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(30)

Menü

Weitere Dienste

Einstellungen

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

SP-0008 STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS STANDARD IN EARLY-STAGE NSCLC

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy

256 INVITED Intensity Modulated Radiotherapy: Fixed-Beam and Arc Delivery Techniques for Locally Advanced Disease

ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy

The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma

Curative Radiotherapy for Non-small Cell Lung Cancer: Practice Changing and Changing Practice?

Deep Learning and Internet of Things (IoT) Based Monitoring System for Miners

SP-0761: Combining immunotherapy and thoracic radiotherapy in SCLC

Aktive Filter

Suchergebnisse filtern